Epstein Secrets

nts to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AR (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases

scrutiny "is critical to build trust and confidence" in whichever vaccines emerge. Pfizer Expands Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, ai

/22, Choe, Troise, Veiga) and the Wall Street Journal <https://www.wsj.com/articles/global-stock-markets-dow-update-10-22-2020-11603358278> (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg <https://www.bloomberg.corninews/articles/2020-10-22/yields-up-on-stimulus-hopes-asia-stocks

eens. USA Today <https://www.usatoday.com/story/news/health/2020/10/22kovid-vaccine-children-clinical-trials-pfizer- cincinnati/3709031001/> (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aim

nts to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AP (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases

scrutiny "is critical to build trust and confidence" in whichever vaccines emerge. Pfizer Expands Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, ai